Jay Timmons, NAM CEO

Drug man­u­fac­tur­ers are fight­ing mad about pric­ing leg­is­la­tion and they're tak­ing the next round pub­lic

While drug pric­ing re­form is snaking its way through Con­gress, the pro­posed leg­is­la­tion is fac­ing some op­po­si­tion from in­dus­try groups, as the Na­tion­al As­so­ci­a­tion of …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.